Skip to content

Assessment of cinnamon effects in type 2 diabetic patients

Assessment of cinnamon effects on advanced glycation end products, plasma vascular and systematic inflammation factors, antioxidant status, NF-kB and Sirtuin1 activity in mononuclear cells in type 2 diabetic patients

Status
Active, not recruiting
Phases
Phase 2
Study type
Interventional
Source
IRCT
Registry ID
IRCT2016061128392N1
Enrollment
44
Registered
2016-07-01
Start date
2016-03-19
Completion date
Unknown
Last updated
2018-02-22

For informational purposes only — not medical advice. Sourced from public registries and may not reflect the latest updates. Terms

Conditions

DIABETES. Non-insulin-dependent diabetes mellitus without complications

Interventions

Intervention 1: The intervention group: capsules 1 gr Cinnamon, 3 times per day, for 8 weeks. Intervention 2: Control group: capsules 1 gr microcristalin cellulose, 3 times per day, for 8 weeks.
Treatment - Drugs
The intervention group: capsules 1 gr Cinnamon, 3 times per day, for 8 weeks.
Control group: capsules 1 gr microcristalin cellulose, 3 times per day, for 8 weeks.

Sponsors

National Nutrition & Food Technology Research Institute (NNFTRI)
Lead Sponsor
Research Institute for Endocrine Sciences, Shahid Beheshti University of Medical Sciences
Collaborator

Eligibility

Sex/Gender
All
Age
70 Years to 25 Years

Inclusion criteria

Inclusion criteria: Inclusion criteria : Having type 2 diabetes for at least 10 years? FBS <180 and 2 h-blood-sugar <250 mg/dl? no pregnancy or lactation? no autoimmune disorder? without any thyroid , kidney , CVD diseases, thyroid and chronic inflammatory diseases, peptic ulcer and infection? no regular consumption of cinnamon or other herbal drugs? no sensitivity People who are just using the pills (not insulin)? your diabetes control cinnamon? body mass index (BMI) <30 kg/m ? Age between 70-25 years. Exclusion criteria : No observation of research protocol (no consumption of more than 20% of the capsules)? any sensitivity due to cinnamon consumption reported by the patient or noticed after the outset of the study? consumption of alcohol or narcotic drugs? and any variation in patients’ routine treatment according to physicians’ resolution (i.e., variation in type and dose of the drugs to be consumed, and treatment with insulin)? Pregnancy during the study.

Exclusion criteria

Exclusion criteria:

Design outcomes

Primary

MeasureTime frame
Sirtuin Activity 1. Timepoint: Before and after the intervention. Method of measurement: ng/ml.;Fasting insulin. Timepoint: Before and after the intervention. Method of measurement: mU/L.;HOMA-IR. Timepoint: Before and after the intervention. Method of measurement: %.;Fasting plasma glucose. Timepoint: Before and after the intervention. Method of measurement: mg/dl.;Carboxymethyl-lysine plasma. Timepoint: Before and after the intervention. Method of measurement: ng/ml.;Hb A1c. Timepoint: Before and after the intervention. Method of measurement: %.;The activity NF-kB. Timepoint: Before and after the intervention. Method of measurement: ng/ml.;VCAM-1. Timepoint: Before and after the intervention. Method of measurement: ng/ml.;Hs-CRP. Timepoint: Before and after the intervention. Method of measurement: ng/ml.;IL-6. Timepoint: Before and after the intervention. Method of measurement: ng/L.;TNF. Timepoint: Before and after the intervention. Method of measurement: ng/L.;ICAM-1. Timepoint: Before and after the intervention. Method of measurement: ng/ml.

Secondary

MeasureTime frame
Vitamin E diet. Timepoint: Before and after the intervention. Method of measurement: mg/day.;MUFA. Timepoint: Before and after the intervention. Method of measurement: gr/day.;PUFA. Timepoint: Before and after the intervention. Method of measurement: gr/day.;Salt diet. Timepoint: Before and after the intervention. Method of measurement: gr/day.;SAFA. Timepoint: Before and after the intervention. Method of measurement: gr/day.;Fat Diet. Timepoint: Before and after the intervention. Method of measurement: gr/day.;Cholesterol diet. Timepoint: Before and after the intervention. Method of measurement: mg/day.;Dietary fiber. Timepoint: Before and after the intervention. Method of measurement: mg/day.;Protein Diet. Timepoint: Before and after the intervention. Method of measurement: gr/day.;BMI. Timepoint: Before and after the intervention. Method of measurement: Kilograms per square meter.;Carb Diet. Timepoint: Before and after the intervention. Method of measurement: gr/day.;Total dietary energy. Timepoint: Before and after the intervention. Method of measurement: Kcal/day.;Vitamin C diet. Timepoint: Before and after the intervention. Method of measurement: mg/day.;Selenium diet. Timepoint: Before and after the intervention. Method of measurement: mcg/day.

Countries

Iran (Islamic Republic of)

Contacts

Public ContactBehrouz Talaei

Shahid Beheshti University of Medical Sciences Faculty of Nutrition Sciences and food technology

B_TALAEI@HOTMAIL.COM+98 21 2236 0656

Outcome results

None listed

Source: IRCT (via WHO ICTRP) · Data processed: Feb 4, 2026